Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01015222
Title Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Methylnaltrexone Bromide

Dasatinib

Paclitaxel

Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.